Evidence map›Paper›PMID 39980301›Full record

ArticleJournal of the National Cancer Institute2025

Colon, colorectal, and all cancer incidence increase in the young due to appendix reclassification.

Archie Bleyer, Lynn A G Ries, Danielle B Cameron, Sara A Mansfield, Stuart E Siegel, Ronald D Barr

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Recent trends in Early-Onset cancer incidence rates.Journal of the National Cancer Institute · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Roles and Implications of m6A Methylation in Radiotherapy for Gastrointestinal Tumors.Dose-response : a publication of International Hormesis Society
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Archie BleyerDepartment of Radiation Medicine, Oregon Health and Science University, Portland, OR 97703, United States.ORCID 0000-0001-7738-5146
Lynn A G RiesRiesSearch LLC, Rockville, MD, United States.ORCID 0000-0003-3754-1479
Danielle B CameronPediatric Surgery, Massachusetts General Hospital, Boston, MA, United States.
Sara A MansfieldPediatric Surgery, Nationwide Childrens' Hospital, Columbus, OH, United States.ORCID 0000-0002-2868-0947
Stuart E SiegelCureSearch and Adolescent and Young Adult Cancer Coalition, United States.ORCID 0000-0002-4305-1874
Ronald D BarrDepartments of Pediatrics and Medicine, McMaster University, Hamilton, ON 97703, Canada.ORCID 0000-0002-5711-7440

Funding

NCI NIH HHS
6 · The paper itself

Abstract

backgroundIncreases in colon and colorectal cancer incidence among adolescents and young adults have been reported progressively. Most of the increase may be because of an artifact caused by reclassifying appendiceal carcinoids and neuroendocrine tumor (NET) as malignant.

methodsAge-adjusted incidence and survival data were obtained from the Surveillance, Epidemiology, and End Results SEER22 database.

resultsIn adolescents and young adults during 2000-2020, appendix cancer had an average annual percent change in incidence increase that in males was 3.7 times greater than the next most increasing cancer (average annual percent change = 12.8, 95% confidence interval CI] = 10.9% to 14.6% vs average annual percent change = 3.4 [kidney], 95% CI = 2.7% to 3.5%) and correspondingly in females 2.9-fold greater (average annual percent change = 14.6,95% CI = 11.9% to 17.3% vs average annual percent change = 4.2 [pancreas], 95% CI = 3.6% to 4.8%). From 2000-2009 to 2015-2020, appendix cancer incidence increased 17-, 6.5-, and 2.5-fold in children aged 0-14 years, adolescents and young adults aged 15-39 years, and adults aged 40-49 years, respectively. NET accounted for 95%, 90%, and 80% of appendix cancer increase in the 3 age groups, respectively. In 3446 adolescents and young adults diagnosed during 2010-2020 with malignant appendix NET, the 6-year cancer-specific survival was 99.4% (95% CI = 99.0% to 99.6%). From 2000-2009 to 2015-2020, colon carcinoma incidence in adolescents and young adults increased 61% with the appendix included and only 11% with the appendix excluded.

conclusionsReclassification of appendix NET/carcinoids as malignant has artifactually increased the incidence of colon, colorectum, and all cancer in children and adolescents and young adults. Appendix NET/carcinoids are rarely fatal in those aged younger than 40 years and should not be considered as cancer and included in colorectal cancer analyses. To the extent that the appendix artifact occurs in adults aged 40-49 years, recommendations for starting colorectal cancer screening earlier may be affected.

Indexed as

Appendiceal NeoplasmsCarcinoid TumorColonic NeoplasmsColorectal NeoplasmsNeuroendocrine TumorsAdolescentAdultChildChild, PreschoolFemaleHumansIncidenceInfantMaleMiddle AgedSEER Program

Identifiers

PMID39980301
PMCPMC12229466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.